Home LiteratureArticle Details
PMID: 8472873 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Structural and functional characterization of the rat follistatin (activin-binding protein) gene promoter.

Molecular and cellular endocrinology ·Vol. 92 ·No. 1 ·1993-03-00 ·Pages 99-109

Miyanaga K, Shimasaki S

Abstract

Follistatin was originally identified as a specific inhibitor of follicle stimulating hormone secretion and later characterized as a binding protein for activin. Since activin regulates hormone secretion and cell differentiation, the importance of understanding the mechanisms regulating the synthesis of its binding protein, follistatin, is evident. To study the regulation of follistatin gene expression, we first determined the transcription start site (cap site) of the rat follistatin gene using primer extension and ribonuclease protection assay. Our results led to the identification of multiple cap sites located at three different positions of the promoter. DNA sequence analysis revealed that each cap site was located at approximately 30 nucleotide (nt) downstream of three distinct TATA-like sequences. In primary cultures of rat granulosa cells, transfection studies using 5'-flanking regions of follistatin gene fused to the chloramphenicol acetyltransferase (CAT) reporter gene revealed the presence of two DNA segments that act to suppress basal transcriptional activity. The promoter activity of the CAT construct containing 2.6 kilo base pairs (kb) of 5'-flanking region was induced 2.5-fold above basal activity by forskolin (10 microM), and 1.6-fold by 12-O-tetradecanoylphorbol 13-acetate (TPA, 100 nM). Co-treatment with forskolin and TPA resulted in a 6.4-fold induction in its promoter activity, suggesting that two distinct signal transduction pathways, the cAMP-dependent protein kinase-A pathway and diacylglycerol-dependent protein kinase-C pathway, act coordinately to modulate follistatin gene transcription. Experiments using a series of 5'-flanking region deletion constructs located the regulatory regions responsive to these two pharmacological agents at nt -312 to -32 and -35 to +139.

MeSH Terms
Activins Amino Acid Sequence Animals Base Sequence Cells, Cultured Colforsin/pharmacology Female Follistatin Gene Expression Regulation/drug effects Genes Genes, Synthetic Glycoproteins/genetics Granulosa Cells/metabolism Inhibins/metabolism Molecular Sequence Data Promoter Regions, Genetic RNA Caps Rats Rats, Sprague-Dawley Recombinant Fusion Proteins/biosynthesis Tetradecanoylphorbol Acetate/pharmacology
Chemicals
Follistatin Glycoproteins RNA Caps Recombinant Fusion Proteins Activins Colforsin Inhibins Tetradecanoylphorbol Acetate
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Miyanaga K
Department of Molecular Endocrinology, Whittier Institute for Diabetes and Endocrinology, La Jolla, CA 92037.
Shimasaki S
Article Info
Journal
Molecular and cellular endocrinology
Abbr.
Mol Cell Endocrinol
ISSN
0303-7207
Published
1993-03-00
Pages
99-109
Language
English
Region
Ireland
NLM ID
7500844
Subset
IM
Grants
NICHD NIH HHS · P01-HD-09690 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com